Equities

Tinavi Medical Technologies Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Tinavi Medical Technologies Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)24.84
  • Today's Change-0.600 / -2.36%
  • Shares traded10.78m
  • 1 Year change+107.87%
  • Beta1.7253
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Tinavi Medical Technologies Co Ltd is a China-based company mainly engaged in the research, development, production, sales and service of orthopedic surgery navigation and positioning robots. The Company's products and services for medical institutions mainly include orthopedic surgery navigation and positioning robots, GD-A, GD-2000/GD-S and TiRobot, surgery center professional engineering, supporting equipment and consumables and technology services. The Company mainly conducts its businesses within the domestic market.

  • Revenue in CNY (TTM)274.20m
  • Net income in CNY-159.01m
  • Incorporated2010
  • Employees307.00
  • Location
    Tinavi Medical Technologies Co LtdRoom 206, 2F, Building 1, Zone C, DongshBEIJING 100096ChinaCHN
  • Phone+86 1 082156660
  • Fax+86 1 082947808
  • Websitehttps://cn.tinavi.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Haohai Biological Tech Co Ltd2.52bn384.21m10.01bn2.16k28.541.92--3.971.651.6510.8324.490.35121.537.841,169,728.004.944.585.965.2669.1370.3914.0714.673.24--0.065642.371.6410.951.042.55-1.8614.87
Shanghai Runda Medical Technology Co Ltd7.40bn-157.84m10.04bn3.14k--2.40--1.36-0.2609-0.260912.466.920.52373.681.462,360,202.00-0.55773.81-1.4910.1921.9826.78-1.065.440.97231.160.560515.85-9.133.34-79.77-29.14-4.52--
Qingdao Haier Biomedical Co Ltd2.26bn255.88m10.39bn2.81k40.302.41--4.590.81440.81447.2113.640.40084.315.12806,199.104.6810.875.9214.1245.3149.2111.6724.082.41--0.020528.140.128817.67-9.7115.03-5.5321.16
Xiangyu Medical Co Ltd773.93m73.51m10.88bn2.34k142.005.37--14.060.47890.47895.0712.670.25481.0111.40330,597.702.358.543.2610.1765.9866.789.2228.370.9871--0.238732.49-0.171711.71-54.68-4.4183.55--
Shanghai Microport EP MedTech Co Ltd458.70m52.26m11.21bn500.00214.596.26--24.450.1110.1110.97473.810.23951.336.85917,403.002.730.90842.910.957958.2464.9511.394.0910.17--0.00320.0025.5128.61815.36--35.67--
Beijing Wandong Medical Technolgy Co Ltd1.62bn14.41m11.31bn1.19k965.792.42--6.980.01670.01672.266.660.29372.732.991,360,016.000.26234.510.3045.2131.5942.820.893314.914.80--0.003943.2523.269.18-16.54-1.40-1.3921.06
Sansure Biotech Inc1.67bn271.49m11.59bn2.35k45.181.63--6.940.44270.44272.4512.310.18521.042.46711,687.902.5021.182.8124.3773.7068.6013.4940.514.49--0.171625.7444.7831.89-24.2347.5065.28--
TINAVI Medical Technologies Co Ltd274.20m-159.01m11.60bn307.00--9.29--42.31-0.3493-0.34930.60352.740.16732.187.63893,155.40-10.37-8.02-11.54-9.1670.0969.64-62.01-63.512.94-15.750.1408---14.85-4.8722.54--12.71--
Eyebright Medical Technlgy (Bjng) Co Ltd1.48bn360.97m11.67bn2.29k32.054.15--7.891.881.887.7114.530.40481.893.34644,799.409.9010.5011.5412.0462.9175.1324.4531.923.2824.660.175320.1148.2448.5127.7742.2518.40--
Shandong Weigao Orthopaedic Devce Co Ltd1.48bn266.86m11.93bn2.07k44.712.93--8.090.66720.66723.7010.180.29190.77985.17714,278.405.369.006.5811.0564.2274.0718.3724.984.28--0.001122.9013.18-1.5999.22-12.72-3.40--
Vcanbio Cell & Gene Engineering Corp Ltd1.47bn74.75m12.09bn2.01k156.853.26--8.210.16470.16473.297.930.27781.922.35730,874.401.071.241.511.7667.2968.073.854.201.604.900.02190.00-0.27052.71-5.7315.09-11.35--
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.25bn377.82m12.20bn832.0031.783.08--9.753.123.1210.2732.100.26941.563.661,515,185.007.9415.389.1016.8768.1075.3829.4541.854.36--0.004346.521.6129.301.9628.7858.5335.76
Data as of Feb 11 2026. Currency figures normalised to Tinavi Medical Technologies Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

10.58%Per cent of shares held by top holders
HolderShares% Held
E Fund Management Co., Ltd.as of 30 Sep 202510.78m3.18%
China Asset Management Co., Ltd.as of 30 Sep 20258.72m2.57%
Great Wall Fund Management Co., Ltd.as of 30 Jun 20254.69m1.38%
Lion Fund Management Co., Ltd.as of 30 Jun 20253.18m0.94%
Tian Hong Asset Management Co., Ltd.as of 30 Jun 20252.96m0.87%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20252.44m0.72%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 20251.03m0.30%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025858.23k0.25%
Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2025762.01k0.23%
Bosera Asset Management Co., Ltd.as of 30 Jun 2025488.70k0.14%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.